Biomea Fusion released a new Dr. Biomea episode explaining the stages of clinical trials and why they matter in bringing new medicines to market. The outreach c

Biomea Fusion released a new Dr. Biomea episode explaining the stages of clinical trials and why they matter in bringing new medicines to market. The outreach comes as the company continues to highlight Phase II updates for icovamenib in type 1 diabetes.